MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
Genome Medicine2011Vol. 3(8), pp. 56–56
Citations Over TimeTop 10% of 2011 papers
Abstract
MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mesenchymal transition. These new insights into the roles of miR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice.
Related Papers
- → Society of Surgical Oncology SSO 2023 - International Conference on Surgical Cancer Care(2023)3 cited
- → ASO Author Reflections: Investigating the Relationship Between Patient Primary Language and Surgical Oncology Outcomes(2022)1 cited
- → Controversies in Gynaecologic Oncology(2017)1 cited
- → Abstracts exchange: European Journal of Surgical Oncology(1996)
- → ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match(2022)